Mounjaro, developed by Eli Lilly, received FDA approval in May 2022, while Wegovy, produced by Novo Nordisk, was approved in June 2021. Both medications have shown promising results in clinical trials, with participants losing a considerable percentage of their body weight over extended periods. The growing body of research supporting these drugs underscores their potential … Read more
In response to this escalating crisis, Indian pharmaceutical companies have begun developing and producing affordable weight-loss drugs, which are drawing attention from international markets. These medications, including those based on semaglutide and liraglutide, have shown promising results in clinical trials, leading to significant weight loss in patients, as noted in a recent article on the … Read more
The Growing Concern of Obesity in Cats Recent studies have highlighted a rising trend in obesity among domestic cats, with estimates suggesting that approximately 60% of felines in the United States are overweight or obese. This alarming statistic not only raises concerns about the health of these pets but also reflects broader issues related to … Read more
The Rising Problem of Obesity in Cats As pet obesity rates continue to climb, veterinarians are increasingly concerned about the health implications for cats. Recent studies indicate that approximately 60% of cats in the United States are classified as overweight or obese, a statistic that has doubled over the past two decades. This trend raises … Read more
